AIRLINK 74.64 Decreased By ▼ -0.21 (-0.28%)
BOP 5.01 Increased By ▲ 0.03 (0.6%)
CNERGY 4.51 Increased By ▲ 0.02 (0.45%)
DFML 42.44 Increased By ▲ 2.44 (6.1%)
DGKC 87.02 Increased By ▲ 0.67 (0.78%)
FCCL 21.58 Increased By ▲ 0.22 (1.03%)
FFBL 33.54 Decreased By ▼ -0.31 (-0.92%)
FFL 9.66 Decreased By ▼ -0.06 (-0.62%)
GGL 10.43 Decreased By ▼ -0.02 (-0.19%)
HBL 114.29 Increased By ▲ 1.55 (1.37%)
HUBC 139.94 Increased By ▲ 2.50 (1.82%)
HUMNL 12.25 Increased By ▲ 0.83 (7.27%)
KEL 5.21 Decreased By ▼ -0.07 (-1.33%)
KOSM 4.50 Decreased By ▼ -0.13 (-2.81%)
MLCF 38.09 Increased By ▲ 0.29 (0.77%)
OGDC 139.16 Decreased By ▼ -0.34 (-0.24%)
PAEL 25.87 Increased By ▲ 0.26 (1.02%)
PIAA 22.20 Increased By ▲ 1.52 (7.35%)
PIBTL 6.80 No Change ▼ 0.00 (0%)
PPL 123.58 Increased By ▲ 1.38 (1.13%)
PRL 26.81 Increased By ▲ 0.23 (0.87%)
PTC 14.01 Decreased By ▼ -0.04 (-0.28%)
SEARL 58.53 Decreased By ▼ -0.45 (-0.76%)
SNGP 68.01 Decreased By ▼ -0.94 (-1.36%)
SSGC 10.47 Increased By ▲ 0.17 (1.65%)
TELE 8.39 Increased By ▲ 0.01 (0.12%)
TPLP 11.05 Decreased By ▼ -0.01 (-0.09%)
TRG 63.21 Decreased By ▼ -0.98 (-1.53%)
UNITY 26.59 Increased By ▲ 0.04 (0.15%)
WTL 1.42 Decreased By ▼ -0.03 (-2.07%)
BR100 7,941 Increased By 103.5 (1.32%)
BR30 25,648 Increased By 196 (0.77%)
KSE100 75,983 Increased By 868.6 (1.16%)
KSE30 24,445 Increased By 330.8 (1.37%)

LAHORE: The University of Health Sciences (UHS) has conferred a Ph.D. degree upon Dr. Aisha Hameed in the field of Hematology, following completion of coursework and research focused on chronic lymphocytic leukemia (CLL).

The approval of the award was given in the 199th meeting of UHS Advanced Studies and Research Board (ASRB) held with the vice-chancellor, Prof. Ahsan Waheed Rathore in the chair.

Dr. Aisha Hameed conducted a study on the clinico-hematological and genetic characteristics of patients with chronic lymphocytic leukemia. The title of her research article is "Clinical Utility of CLL-IPI Scoring System in Pakistani Chronic Lymphocytic Patients: A Single-Center Experience," which has been published in the "Pakistan Journal of Medical Sciences."

Given the highly variable clinical course of chronic lymphocytic leukemia, extensive research has been conducted to develop prognostic scoring systems capable of accurately predicting disease behavior and outcomes. These prognostic models primarily emphasize molecular biomarkers of the disease. However, such molecular biomarker-based prognostic systems have never been utilized or validated in our CLL patients prior to this study.

Dr. Aisha Hameed's research marks the first instance in Pakistan of assessing the clinical utility of the CLL-IPI scoring system in CLL patients. This pioneering work is expected to stimulate further CLL-related research in our country, which currently falls behind international standards. The research was supervised by Prof. Dr. Shagufta Khaliq and co-supervised by Dr. Nadia Sajid and Brig Dr. Nadir Ali (retd). Dr. Hameed's PhD thesis was evaluated by Prof. Dr. Elias Campo from the University of Barcelona, Spain, and Prof. Abhay R. Satoskar from Wexner Medical Center, Ohio State University, USA.

Dr. Aisha Hameed is a medical graduate and holds an M.Phil in Hematology.

Copyright Business Recorder, 2024

Comments

Comments are closed.